Recent discussions on X about Gap Inc. have centered around the company’s stock performance following downgrades by major financial institutions. Posts on the platform highlight a wave of concern over recent analyst actions, with some noting lowered price targets and downgrades to 'Neutral' or 'Equal Weight' due to margin concerns and potential tariff impacts. The conversation reflects a cautious outlook as investors await the upcoming quarterly earnings report, hoping for clarity on these issues.
Despite the unease, there are flickers of optimism among some users who believe the stock could rebound if earnings exceed expectations. Many are keenly watching how Gap might navigate pricing power challenges in a tough macro environment, with tariff-related headwinds adding to the uncertainty. This mix of apprehension and faint hope keeps the dialogue dynamic and engaging as the earnings date approaches.
Note: This discussion summary was generated from an AI condensation of post data.
Gap Inc. Congressional Stock Trading
Members of Congress have traded $GAP stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $GAP stock by members of Congress over the last 6 months:
- REPRESENTATIVE ANDREW R. GARBARINO sold up to $15,000 on 08/21.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
Gap Inc. Insider Trading Activity
Gap Inc. insiders have traded $GAP stock on the open market 20 times in the past 6 months. Of those trades, 0 have been purchases and 20 have been sales.
Here’s a breakdown of recent trading of $GAP stock by insiders over the last 6 months:
- MARK BREITBARD (President & CEO, Gap Brand) has made 0 purchases and 5 sales selling 87,919 shares for an estimated $2,118,590.
- KATRINA O'CONNELL (Chief Financial Officer) has made 0 purchases and 5 sales selling 96,822 shares for an estimated $1,959,129.
- HORACIO BARBEITO (President & CEO, Old Navy) sold 40,764 shares for an estimated $818,288
- SARAH GILLIGAN (Chief Sup Chn & Transform Ofcr) has made 0 purchases and 4 sales selling 36,091 shares for an estimated $729,842.
- CHRIS BLAKESLEE (President & CEO, Athleta) has made 0 purchases and 2 sales selling 27,282 shares for an estimated $533,070.
- JULIE GRUBER (Chief Legal&Compliance Officer) has made 0 purchases and 2 sales selling 4,423 shares for an estimated $87,807.
- ELISABETH B DONOHUE sold 3,539 shares for an estimated $74,464
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
Gap Inc. Analyst Ratings
Wall Street analysts have issued reports on $GAP in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Evercore ISI Group issued a "Outperform" rating on 07/30/2025
- Goldman Sachs issued a "Buy" rating on 07/22/2025
- JP Morgan issued a "Overweight" rating on 05/19/2025
- Morgan Stanley issued a "Overweight" rating on 05/06/2025
To track analyst ratings and price targets for Gap Inc., check out Quiver Quantitative's $GAP forecast page.
Gap Inc. Price Targets
Multiple analysts have issued price targets for $GAP recently. We have seen 13 analysts offer price targets for $GAP in the last 6 months, with a median target of $25.0.
Here are some recent targets:
- Jay Sole from UBS set a target price of $23.0 on 08/22/2025
- Adrienne Yih from Barclays set a target price of $19.0 on 08/22/2025
- Paul Lejuez from Citigroup set a target price of $22.0 on 08/20/2025
- Lorraine Hutchinson from B of A Securities set a target price of $21.0 on 08/19/2025
- Michael Binetti from Evercore ISI Group set a target price of $24.0 on 07/30/2025
- Brooke Roach from Goldman Sachs set a target price of $26.0 on 07/22/2025
- Dana Telsey from Telsey Advisory Group set a target price of $26.0 on 05/30/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
